InsidersTradesSigma
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Explore the complete record of transactions filed by Pankovcin Corinne, Chief Financial Officer. Director active across 2 companies, notably Aditx Therapeutics, Inc.. Cumulatively, 3 disclosures have been logged. Split: 1 buy · 1 sell. Total volume traded: €3. Activity tracked since 4 June 2021. The latest transaction was disclosed on 25 November 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations
Corinne Pankovcin is the Chief Financial Officer at Aditx Therapeutics, Inc. In this role, she oversees the company's financial operations, including budgeting and risk management. Her expertise is crucial for ensuring the company's financial health.